Supernus’ injection to treat advanced Parkinson’s gets US regulator’s nod
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Drugs
Health
Medical